Cumulative doses of Zolpidem (Ambien), a common sleep drug, are associated with a greater risk for developing Alzheimer's in elderly patients (65 and older) according to a retrospective study.
J Am Geriatr Soc, doi:10.111/jgs.15018
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment